新普京(中国·澳门)娱乐场官方网站-PC platform
Stock Code
603707.SH
ABOUT
>
Company profile
Enterprise Culture
Early Warning System
PRODUCTS
>
Product List
Commercialized Products
INNOVATION
>
Small Molecule Pharmaceuticals
Macromolecule pharmaceuticals
Global Regulatory Registration Support
Commercial cooperation
MEDIA
>
News in NKF
Industry dynamics
CONTACT
CH / EN
Home
>
MEDIA
>
News in NKF
>
新普京澳门娱乐场网站2022春季校园招聘!
2022-02-16
新普京澳门娱乐场网站2022春季校园招聘!
share
Return
Previous
新品氯化琥珀胆碱注射液国外首发
Next
新普京澳门娱乐场网站子公司健进制药注射用卡莫司汀套装首次商业化发运
Relevant recommendations
2024-05-14
Enoxaparin Sodium Injection of NKF approved in Egypt
2024-05-14
Kindos’ (subsidiary of NKF) Bortezomib for injection getting approved by NMPA, submitted to NMPA and US FDA
2024-04-29
Good news! NKF and Livzon export Cetrorelix Acetate for Injection first time to US
2024-04-23
Nanjing King-Friend attains 6 licensing patents.
2024-04-16
Kindos creates the new record for fastest approval by FDA: Dacarbazine for Injection